Elixir Pharmaceuticals withdraws IPO plans
WASHINGTON May 9 (Reuters) - Elixir Pharmaceuticals Inc on Friday filed with regulators to withdraw its plans for an initial public offering due to "market conditions."
The company had previously filed to sell 5 million shares at an estimated price range of $14 to $16 each. (Reporting by Karey Wutkowski; editing by Carol Bishopric)
- Tweet this
- Share this
- Digg this